Company Description
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand.
The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products.
In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products.
It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers.
The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 1988 |
| IPO Date | Mar 16, 2021 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 335 |
| CEO | Michel Brousset |
Contact Details
Address: 81 Fulham Road, Suite 560 London, SW3 6RD United Kingdom | |
| Phone | 44 20 3196 0264 |
| Website | waldencast.com |
Stock Details
| Ticker Symbol | WALD |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 1840199 |
| CUSIP Number | G9503X103 |
| ISIN Number | JE00BPG99318 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Michel Brousset | Founder, Chief Executive Officer and Director |
| Hind Sebti | Co-Founder, Chief Growth Officer and Director |
| Manuel Manfredi | Chief Financial Officer |
| Elisabeth Milan | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 15, 2026 | 6-K | Report of foreign issuer |
| Dec 19, 2025 | 6-K | Report of foreign issuer |
| Dec 18, 2025 | EFFECT | Notice of Effectiveness |
| Dec 18, 2025 | 424B3 | Prospectus |
| Dec 4, 2025 | F-3 | Filing |
| Nov 24, 2025 | 6-K | Report of foreign issuer |
| Nov 24, 2025 | 6-K | Report of foreign issuer |
| Nov 14, 2025 | 6-K | Report of foreign issuer |
| Sep 10, 2025 | 6-K | Report of foreign issuer |
| Sep 4, 2025 | SCHEDULE 13G | Filing |